A carregar...
Effect of Paliperidone Palmitate 3-Month Formulation on Goal Attainment and Disability After 52 Weeks’ Treatment in Patients with Clinically Stable Schizophrenia
PURPOSE: This pragmatic clinical study aimed to assess goal attainment among patients with schizophrenia treated with paliperidone palmitate 3-monthly (PP3M) and its relation to their level of disability, and whether patients achieved symptomatic remission at the study endpoint. PATIENTS AND METHODS...
Na minha lista:
| Publicado no: | Neuropsychiatr Dis Treat |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7767727/ https://ncbi.nlm.nih.gov/pubmed/33380797 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S286654 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|